Rita Nano

Rita Nano

Auto-generated profile, based on publicly available information

Rita Nano

Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2005 in Diabetologia
Verified
Journal Article
Closed access
PDF file
RNR. Nano
R. Nano
BCB. Clissi
B. Clissi
RMR. Melzi
R. Melzi
GCG. Calori
G. Calori
PMP. Maffi
P. Maffi
FBF. Bertuzzi
F. Bertuzzi

8 March 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
IGIacopo Gesmundo
Iacopo Gesmundo
Barbara PardiniBarbara Pardini
Barbara Pardini
EGEleonora Gargantini
Eleonora Gargantini
GGGiacomo Gamba
Giacomo Gamba
GBGiovanni Birolo
Giovanni Birolo
Riccarda GranataRiccarda Granata
Riccarda Granata
Extracellular vesicles (EVs) are implicated in the crosstalk between adipocytes and other metabolic organs, and an altered biological cargo has been observed in EVs from human obese adipose tissue (AT). Yet, the role of adipocyte-derived EVs in pancreatic β cells remains to be determined. Here, we explored the effects of EVs released from adipocytes isolated from both rodents and humans and human AT explants on survival and function of pancreatic β cells and human pancreatic islets. EVs from healthy 3T3-L1 adipocytes increased survival and proliferation and promoted insulin secretion in INS-1E β cells and human pancreatic islets, both those untreated or exposed to cytokines or glucolipotoxicity, whereas EVs from inflamed adipocytes caused β cell death and dysfunction. Human lean adipocyte-derived EVs produced similar beneficial effects, whereas EVs from obese AT explants were harmful for human EndoC-βH3 β cells. We observed differential expression of miRNAs in EVs from healthy and inflamed adipocytes, as well as alteration in signaling pathways and expression of β cell genes, adipokines, and cytokines in recipient β cells. These in vitro results suggest that, depending on the physiopathological state of AT, adipocyte-derived EVs may influence β cell fate and function.

1 November 2006 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
SMS. Marzorati
S. Marzorati
BAB. Antonioli
B. Antonioli
RNR. Nano
R. Nano
PMP. Maffi
P. Maffi
LPLorenzo Piemonti
Lorenzo Piemonti
FBF. Bertuzzi
F. Bertuzzi
A portion of transplanted islets is lost during engraftment as a result of stressful events, involving hypoxia and production of proinflammatory molecules by islets. Two of these molecules (monocyte chemoattractant protein-1, CCL2/MCP-1 and tissue factor, TF) are directly correlated with reduced graft function. We evaluated which factors reduce islet proinflammatory conditions. In particular the effects of different culture media supplemented with proteins or antioxidant agents on CCL2/MCP-1 and TF human islet release were evaluated. We observed that human islets after culture in final wash culture medium (FW) significantly decreased CCL2/MCP-1 release and TF production compared with CMRL and M199. These effects were independent from the type of protein added to the media (human serum, human albumin, fetal calf serum). Glutathione in FW further decreased CCL2/MCP-1 in a dose-dependent manner. Culture conditions can modulate the proinflammatory state of islets, and could be used in clinical islet transplantation to reduce inflammation during engraftment.

1 December 2002 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
LPL. Polastri
L. Polastri
FGF. Galbiati
F. Galbiati
FBF. Bertuzzi
F. Bertuzzi
Paolo FiorinaPaolo Fiorina
Paolo Fiorina
RNR. Nano
R. Nano
ADA.M. Davalli
A.M. Davalli

1 October 1999 in Diabetes
Verified
Journal Article
Closed access
PDF file
FBF Bertuzzi
F Bertuzzi
ADA M Davalli
A M Davalli
RNR Nano
R Nano
CSC Socci
C Socci
FCF Codazzi
F Codazzi
FGF Grohovaz
F Grohovaz
Within pancreatic islet cells, rhythmic changes in the cytosolic Ca2+ concentration have been reported to occur in response to stimulatory glucose concentrations and to be synchronous with pulsatile release of insulin. We explored the possible mechanisms responsible for Ca2+ signal propagation within islet cells, with particular regard to gap junction communication, the pathway widely credited with being responsible for coordination of the secretory activity. Using fura-2 imaging, we found that multiple mechanisms control Ca2+ signaling in pancreatic islet cells. Gap junction blockade by 18 alpha-glycyrrhetinic acid greatly restricted the propagation of Ca2+ waves induced by mechanical stimulation of cells but affected neither Ca2+ signals nor insulin secretion elicited by glucose elevation. The source of Ca2+ elevation was also different under the two experimental conditions, the first being sustained by release from inner stores and the second by nifedipine-sensitive Ca2+ influx. Furthermore, glucose-induced Ca2+ waves were able to propagate across cell-free clefts, indicating that diffusible factors can control Ca2+ signal coordination. Our results provide evidence that multiple mechanisms of Ca2+ signaling operate in beta-cells and that gap junctions are not required for intercellular Ca2+ wave propagation or insulin secretion in response to glucose.

30 September 2022 in Annals of Surgery
Verified
Journal Article
Open access
Gianpaolo BalzanoGianpaolo Balzano
Gianpaolo Balzano
AZAlessandro Zerbi
Alessandro Zerbi
FAFrancesca Aleotti
Francesca Aleotti
GCGiovanni Capretti
Giovanni Capretti
RMRaffella Bsc Melzi
Raffella Bsc Melzi
LPLorenzo Piemonti
Lorenzo Piemonti
Objective: To compare pancreaticoduodenectomy (PD) and total pancreatectomy (TP) with islet autotransplantation (IAT) in patients at high risk of postoperative pancreatic fistula (POPF). Background: Criteria to predict the risk of POPF occurrence after PD are available. However, even when a high risk of POPF is predicted, TP is not currently accepted as an alternative to PD, because of its severe consequences on glycaemic control. Combining IAT with TP may mitigate such consequences. Methods: Randomized, open-label, controlled, bicentric trial (NCT01346098). Candidates for PD at high-risk pancreatic anastomosis (ie, soft pancreas and duct diameter ≤3 mm) were randomly assigned (1:1) to undergo either PD or TP-IAT. The primary endpoint was the incidence of complications within 90 days after surgery. Results: Between 2010 and 2019, 61 patients were assigned to PD (n=31) or TP-IAT (n=30). In the intention-to-treat analysis, morbidity rate was 90·3% after PD and 60% after TP-IAT (P=0.008). According to complications’ severity, PD was associated with an increased risk of grade ≥2 [odds ratio (OR)=7.64 (95% CI: 1.35–43.3), P=0.022], while the OR for grade ≥3 complications was 2.82 (95% CI: 0.86–9.24, P=0.086). After TP-IAT, the postoperative stay was shorter [median: 10.5 vs 16.0 days; P<0.001). No differences were observed in disease-free survival, site of recurrence, disease-specific survival, and overall survival. TP-IAT was associated with a higher risk of diabetes [hazard ratio=9.1 (95% CI: 3.76–21.9), P<0.0001], but most patients maintained good metabolic control and showed sustained C-peptide production over time. Conclusions: TP-IAT may become the standard treatment in candidates for PD, when a high risk of POPF is predicted.